Steven M. Blum

Oncology

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

IL-6 in Checkpoint Myocarditis: A Promising Biomarker and Therapeutic Target.

IL-6 in Checkpoint Myocarditis: A Promising Biomarker and Therapeutic Target.

Journal: JACC. CardioOncology

Published: May 09, 2026

Tumor location as a risk factor for severe immune-related adverse events.

Tumor location as a risk factor for severe immune-related adverse events.

Journal: Journal for immunotherapy of cancer

Published: April 26, 2025

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

Journal: Nature communications

Published: April 17, 2025

Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.

Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 03, 2024

Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases.

Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases.

Journal: Gastroenterology

Published: June 28, 2024

Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.

Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.

Journal: Science advances

Published: November 24, 2023

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.

Journal: bioRxiv : the preprint server for biology

Published: October 04, 2023

Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.

Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.

Journal: Immunological reviews

Published: May 17, 2023

Immune responses in checkpoint myocarditis across heart, blood and tumour.

Immune responses in checkpoint myocarditis across heart, blood and tumour.

Journal: Nature

Published: April 20, 2023

Toxicities associated with immune checkpoint inhibitors: a systematic study.

Toxicities associated with immune checkpoint inhibitors: a systematic study.

Journal: International journal of surgery (London, England)

Published: November 07, 2022

Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma.

Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 19, 2022

Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.

Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.

Journal: Journal of the American Academy of Dermatology

Published: September 14, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026